Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Mucosa | 13 | 2013 | 88 | 3.020 |
Why?
|
Epithelial Cells | 23 | 2015 | 669 | 2.620 |
Why?
|
Asthma | 17 | 2019 | 955 | 2.390 |
Why?
|
HLA-G Antigens | 6 | 2017 | 52 | 2.050 |
Why?
|
Trachea | 24 | 2003 | 293 | 1.960 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2017 | 121 | 1.370 |
Why?
|
Bronchi | 11 | 2015 | 229 | 1.340 |
Why?
|
Respiratory System | 5 | 2017 | 116 | 1.320 |
Why?
|
Wound Healing | 10 | 2009 | 344 | 1.260 |
Why?
|
Apoptosis | 10 | 2006 | 1683 | 1.170 |
Why?
|
Adrenal Cortex Hormones | 5 | 2015 | 263 | 1.050 |
Why?
|
Cell Movement | 12 | 2010 | 758 | 1.000 |
Why?
|
Bronchiolitis Obliterans | 2 | 2014 | 31 | 0.890 |
Why?
|
Muscle, Smooth | 14 | 2015 | 354 | 0.830 |
Why?
|
Microbiota | 2 | 2017 | 381 | 0.780 |
Why?
|
Lung Transplantation | 2 | 2014 | 175 | 0.770 |
Why?
|
Cytokines | 3 | 2015 | 778 | 0.730 |
Why?
|
Cells, Cultured | 23 | 2015 | 2819 | 0.680 |
Why?
|
Lung | 9 | 2015 | 1169 | 0.670 |
Why?
|
Muscle Contraction | 13 | 1997 | 284 | 0.640 |
Why?
|
Eosinophils | 11 | 2017 | 194 | 0.630 |
Why?
|
Interleukin-6 | 1 | 2019 | 256 | 0.620 |
Why?
|
Anti-Inflammatory Agents | 2 | 2015 | 339 | 0.620 |
Why?
|
Postoperative Complications | 3 | 2016 | 2207 | 0.570 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 112 | 0.570 |
Why?
|
Catheter Ablation | 3 | 2015 | 233 | 0.570 |
Why?
|
Bacteria | 2 | 2017 | 447 | 0.560 |
Why?
|
Dexamethasone | 3 | 2015 | 326 | 0.560 |
Why?
|
Guinea Pigs | 19 | 2003 | 171 | 0.540 |
Why?
|
Prednisone | 1 | 2015 | 258 | 0.510 |
Why?
|
Chemotaxis | 5 | 1999 | 72 | 0.510 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2005 | 222 | 0.460 |
Why?
|
Calcitonin Gene-Related Peptide | 5 | 1999 | 38 | 0.450 |
Why?
|
Membrane Glycoproteins | 3 | 2001 | 428 | 0.450 |
Why?
|
Glucocorticoids | 3 | 2015 | 352 | 0.450 |
Why?
|
Immunomodulation | 1 | 2013 | 55 | 0.440 |
Why?
|
Cell Differentiation | 4 | 2013 | 1458 | 0.430 |
Why?
|
Neuromuscular Diseases | 1 | 2012 | 30 | 0.410 |
Why?
|
Th2 Cells | 1 | 2013 | 146 | 0.410 |
Why?
|
Neuropeptides | 3 | 2001 | 112 | 0.390 |
Why?
|
Humans | 57 | 2019 | 86678 | 0.390 |
Why?
|
Rhinitis, Allergic, Seasonal | 2 | 2011 | 179 | 0.390 |
Why?
|
Receptors, Interleukin-13 | 1 | 2010 | 7 | 0.380 |
Why?
|
Receptors, Interleukin-4 | 1 | 2010 | 9 | 0.380 |
Why?
|
Peptides | 3 | 2001 | 639 | 0.380 |
Why?
|
MAP Kinase Signaling System | 2 | 2008 | 192 | 0.370 |
Why?
|
Inflammation Mediators | 1 | 2011 | 155 | 0.370 |
Why?
|
Cyclosporine | 1 | 2011 | 234 | 0.370 |
Why?
|
Lectins | 3 | 2007 | 84 | 0.370 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 150 | 0.370 |
Why?
|
Ribonucleases | 4 | 1996 | 92 | 0.360 |
Why?
|
Inflammation | 1 | 2015 | 923 | 0.360 |
Why?
|
Blood Proteins | 4 | 1996 | 144 | 0.360 |
Why?
|
Male | 40 | 2019 | 40988 | 0.350 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2009 | 55 | 0.340 |
Why?
|
Immune Tolerance | 1 | 2011 | 337 | 0.340 |
Why?
|
Interleukin-4 | 1 | 2009 | 127 | 0.330 |
Why?
|
Transcription Factor RelA | 1 | 2008 | 49 | 0.330 |
Why?
|
Interleukin-1beta | 1 | 2008 | 78 | 0.330 |
Why?
|
Bombesin | 2 | 1999 | 6 | 0.330 |
Why?
|
Cell Line | 8 | 2009 | 2469 | 0.320 |
Why?
|
Graft Rejection | 1 | 2014 | 1065 | 0.320 |
Why?
|
Epithelium | 12 | 2006 | 319 | 0.320 |
Why?
|
Gene Expression Regulation | 4 | 2014 | 1921 | 0.310 |
Why?
|
Budesonide | 2 | 2014 | 45 | 0.310 |
Why?
|
Animals | 41 | 2014 | 26590 | 0.300 |
Why?
|
Cell Division | 8 | 2003 | 696 | 0.280 |
Why?
|
Forced Expiratory Volume | 3 | 2015 | 122 | 0.280 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 977 | 0.270 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2017 | 241 | 0.270 |
Why?
|
fas Receptor | 3 | 2004 | 75 | 0.270 |
Why?
|
Female | 26 | 2019 | 44550 | 0.270 |
Why?
|
Adult | 13 | 2019 | 25659 | 0.260 |
Why?
|
Middle Aged | 15 | 2019 | 25040 | 0.260 |
Why?
|
Acetylcholine | 9 | 1997 | 176 | 0.250 |
Why?
|
Stress, Mechanical | 3 | 2010 | 248 | 0.250 |
Why?
|
Adrenergic beta-Agonists | 2 | 2003 | 72 | 0.250 |
Why?
|
Bronchoscopy | 3 | 2015 | 152 | 0.240 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2016 | 182 | 0.240 |
Why?
|
Epidermal Growth Factor | 3 | 1999 | 119 | 0.240 |
Why?
|
Receptors, Very Late Antigen | 3 | 1999 | 6 | 0.240 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2003 | 36 | 0.230 |
Why?
|
Stress Fibers | 1 | 2003 | 23 | 0.230 |
Why?
|
3T3 Cells | 2 | 2003 | 94 | 0.230 |
Why?
|
Cytoskeleton | 2 | 2003 | 193 | 0.230 |
Why?
|
Prostaglandins | 2 | 1993 | 43 | 0.220 |
Why?
|
Cytoskeletal Proteins | 2 | 2001 | 223 | 0.220 |
Why?
|
Phospholipases A | 2 | 1993 | 45 | 0.220 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 301 | 0.210 |
Why?
|
Endothelins | 2 | 1992 | 35 | 0.210 |
Why?
|
Mucins | 1 | 2001 | 39 | 0.200 |
Why?
|
Growth Substances | 1 | 2001 | 80 | 0.200 |
Why?
|
Ganglia, Spinal | 3 | 1997 | 72 | 0.200 |
Why?
|
Actins | 2 | 2003 | 451 | 0.200 |
Why?
|
Anti-Asthmatic Agents | 3 | 2014 | 76 | 0.200 |
Why?
|
Trans-Activators | 1 | 2004 | 429 | 0.200 |
Why?
|
Phosphorylation | 4 | 2009 | 1106 | 0.200 |
Why?
|
Depsipeptides | 1 | 2001 | 29 | 0.200 |
Why?
|
Peroxidases | 4 | 1994 | 34 | 0.190 |
Why?
|
Biomarkers | 3 | 2017 | 1718 | 0.190 |
Why?
|
Muscle Proteins | 1 | 2001 | 132 | 0.190 |
Why?
|
Severity of Illness Index | 2 | 2015 | 1802 | 0.180 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2009 | 28 | 0.180 |
Why?
|
Polylysine | 3 | 1997 | 33 | 0.180 |
Why?
|
Peptide Fragments | 2 | 1999 | 460 | 0.180 |
Why?
|
Immunoglobulin E | 2 | 2017 | 144 | 0.180 |
Why?
|
Sympathetic Nervous System | 2 | 1990 | 104 | 0.170 |
Why?
|
Integrin beta1 | 1 | 1999 | 33 | 0.170 |
Why?
|
Kinetics | 10 | 2001 | 1513 | 0.170 |
Why?
|
Allergens | 2 | 2014 | 179 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2014 | 1961 | 0.170 |
Why?
|
Phenotype | 4 | 2019 | 2380 | 0.160 |
Why?
|
Wounds, Stab | 1 | 1997 | 9 | 0.160 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 1208 | 0.160 |
Why?
|
Pneumonia | 2 | 1998 | 179 | 0.160 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2011 | 87 | 0.150 |
Why?
|
Sputum | 1 | 2017 | 34 | 0.150 |
Why?
|
Databases, Genetic | 2 | 2015 | 260 | 0.150 |
Why?
|
Neurokinin B | 1 | 1997 | 1 | 0.150 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 74 | 0.150 |
Why?
|
Metabolome | 1 | 2017 | 47 | 0.150 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 113 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 79 | 0.150 |
Why?
|
Flow Cytometry | 5 | 1999 | 679 | 0.150 |
Why?
|
Metered Dose Inhalers | 1 | 2017 | 33 | 0.140 |
Why?
|
Vital Capacity | 1 | 2016 | 64 | 0.140 |
Why?
|
DNA, Bacterial | 1 | 2017 | 236 | 0.140 |
Why?
|
Enteral Nutrition | 1 | 2016 | 102 | 0.140 |
Why?
|
Gastrostomy | 1 | 2016 | 69 | 0.140 |
Why?
|
Knowledge Bases | 1 | 2015 | 14 | 0.140 |
Why?
|
Integrative Medicine | 1 | 2015 | 8 | 0.140 |
Why?
|
Bradykinin | 2 | 1993 | 46 | 0.140 |
Why?
|
Tachykinins | 1 | 1995 | 12 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2017 | 278 | 0.130 |
Why?
|
RNA, Bacterial | 1 | 2015 | 108 | 0.130 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2015 | 19 | 0.130 |
Why?
|
Time Factors | 5 | 2014 | 5214 | 0.130 |
Why?
|
Eosinophilia | 1 | 2015 | 84 | 0.130 |
Why?
|
Dogs | 8 | 2001 | 686 | 0.130 |
Why?
|
Laminin | 3 | 2001 | 85 | 0.130 |
Why?
|
Nedocromil | 1 | 2014 | 6 | 0.130 |
Why?
|
In Vitro Techniques | 9 | 1997 | 989 | 0.130 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2015 | 41 | 0.130 |
Why?
|
alpha-N-Acetylgalactosaminidase | 1 | 2014 | 4 | 0.130 |
Why?
|
Sirtuin 1 | 1 | 2014 | 32 | 0.120 |
Why?
|
Diaphragm | 1 | 2014 | 50 | 0.120 |
Why?
|
Pregnenediones | 1 | 2014 | 8 | 0.120 |
Why?
|
Fatty Acid Desaturases | 1 | 2014 | 17 | 0.120 |
Why?
|
Serotonin | 4 | 1993 | 218 | 0.120 |
Why?
|
Respiration Disorders | 1 | 2014 | 39 | 0.120 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2005 | 125 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2014 | 35 | 0.120 |
Why?
|
Blotting, Western | 3 | 2001 | 782 | 0.120 |
Why?
|
Solubility | 1 | 2014 | 177 | 0.120 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2013 | 7 | 0.120 |
Why?
|
Rhinovirus | 1 | 2013 | 25 | 0.120 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 7 | 1997 | 39 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2017 | 351 | 0.120 |
Why?
|
Vitamins | 1 | 2014 | 81 | 0.120 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 246 | 0.120 |
Why?
|
Mast Cells | 2 | 2014 | 92 | 0.110 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2015 | 165 | 0.110 |
Why?
|
Cell Cycle | 1 | 1995 | 502 | 0.110 |
Why?
|
Potassium Chloride | 3 | 1997 | 87 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 2 | 2009 | 24 | 0.110 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 103 | 0.110 |
Why?
|
Neurons | 3 | 1997 | 1547 | 0.110 |
Why?
|
Cytochalasin D | 2 | 2003 | 14 | 0.110 |
Why?
|
Acute Disease | 1 | 2014 | 826 | 0.110 |
Why?
|
Virus Replication | 1 | 2013 | 319 | 0.100 |
Why?
|
Cell Line, Transformed | 3 | 2007 | 154 | 0.100 |
Why?
|
Autophagy | 1 | 2013 | 149 | 0.100 |
Why?
|
Histamine | 2 | 1989 | 126 | 0.100 |
Why?
|
Biopsy | 1 | 2015 | 1163 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2014 | 243 | 0.100 |
Why?
|
Fibroblasts | 1 | 2014 | 729 | 0.100 |
Why?
|
Bronchoconstriction | 1 | 1991 | 55 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 425 | 0.100 |
Why?
|
Skin | 1 | 2014 | 554 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 231 | 0.100 |
Why?
|
Swine | 2 | 1990 | 555 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 639 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2011 | 70 | 0.100 |
Why?
|
Chemokine CCL26 | 1 | 2010 | 1 | 0.100 |
Why?
|
Rats | 6 | 2009 | 3992 | 0.100 |
Why?
|
Chemokines, CC | 1 | 2010 | 34 | 0.090 |
Why?
|
Acidosis | 1 | 1990 | 55 | 0.090 |
Why?
|
Eosinophil Granule Proteins | 4 | 1996 | 20 | 0.090 |
Why?
|
Hypercapnia | 1 | 1990 | 43 | 0.090 |
Why?
|
Models, Genetic | 1 | 2015 | 926 | 0.090 |
Why?
|
Protein Subunits | 1 | 2010 | 122 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 179 | 0.090 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 1384 | 0.090 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 1621 | 0.090 |
Why?
|
STAT6 Transcription Factor | 1 | 2009 | 28 | 0.090 |
Why?
|
Isoproterenol | 2 | 1989 | 59 | 0.090 |
Why?
|
Vasomotor System | 1 | 1989 | 12 | 0.090 |
Why?
|
Young Adult | 2 | 2019 | 5980 | 0.090 |
Why?
|
Air | 1 | 2009 | 62 | 0.090 |
Why?
|
Genes, Dominant | 1 | 2009 | 117 | 0.090 |
Why?
|
Sympathomimetics | 1 | 1989 | 12 | 0.090 |
Why?
|
Antigens, Helminth | 1 | 1989 | 22 | 0.090 |
Why?
|
Histamine Release | 1 | 1989 | 53 | 0.080 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2008 | 33 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 68 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 262 | 0.080 |
Why?
|
Muscle Relaxation | 1 | 1988 | 18 | 0.080 |
Why?
|
Hypotension | 1 | 1989 | 70 | 0.080 |
Why?
|
Substance P | 3 | 1999 | 61 | 0.080 |
Why?
|
Aged | 6 | 2017 | 18423 | 0.080 |
Why?
|
DNA, Complementary | 1 | 2009 | 393 | 0.080 |
Why?
|
STAT3 Transcription Factor | 1 | 2008 | 78 | 0.080 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2008 | 67 | 0.080 |
Why?
|
Molecular Chaperones | 1 | 2008 | 111 | 0.080 |
Why?
|
Survival Analysis | 3 | 2016 | 1538 | 0.080 |
Why?
|
MicroRNAs | 1 | 2013 | 534 | 0.080 |
Why?
|
Prospective Studies | 2 | 2015 | 4214 | 0.080 |
Why?
|
Cell Adhesion | 3 | 2001 | 420 | 0.080 |
Why?
|
Neurokinin A | 3 | 1999 | 12 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1989 | 152 | 0.080 |
Why?
|
Microscopy, Video | 2 | 1998 | 34 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 879 | 0.080 |
Why?
|
Enzyme Activation | 2 | 2009 | 692 | 0.080 |
Why?
|
Annexin A2 | 1 | 2007 | 1 | 0.080 |
Why?
|
Heat-Shock Proteins | 1 | 2008 | 179 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 302 | 0.080 |
Why?
|
Insulin | 3 | 1999 | 1160 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 547 | 0.080 |
Why?
|
Gene Expression | 2 | 2004 | 1284 | 0.070 |
Why?
|
Collagen | 2 | 1999 | 269 | 0.070 |
Why?
|
Mice | 4 | 2014 | 11356 | 0.070 |
Why?
|
Epinephrine | 3 | 1992 | 84 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 503 | 0.070 |
Why?
|
Norepinephrine | 3 | 1992 | 167 | 0.070 |
Why?
|
Capsaicin | 4 | 1999 | 44 | 0.070 |
Why?
|
Fibronectins | 2 | 1998 | 93 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 2357 | 0.070 |
Why?
|
Receptors, Tachykinin | 2 | 1995 | 9 | 0.070 |
Why?
|
Administration, Inhalation | 2 | 2017 | 188 | 0.060 |
Why?
|
Dinoprostone | 2 | 1997 | 69 | 0.060 |
Why?
|
Culture Media | 2 | 1998 | 147 | 0.060 |
Why?
|
Mucous Membrane | 2 | 1997 | 83 | 0.060 |
Why?
|
Eosinophil Peroxidase | 3 | 1994 | 14 | 0.060 |
Why?
|
Glycosylation | 2 | 2007 | 129 | 0.060 |
Why?
|
Smad7 Protein | 1 | 2004 | 7 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2004 | 125 | 0.060 |
Why?
|
Cytochalasin B | 5 | 1997 | 19 | 0.060 |
Why?
|
Cyclin E | 1 | 2004 | 27 | 0.060 |
Why?
|
Antibodies, Monoclonal | 3 | 2000 | 1376 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2015 | 196 | 0.060 |
Why?
|
Benzamides | 2 | 1995 | 229 | 0.060 |
Why?
|
Cyclins | 1 | 2004 | 82 | 0.060 |
Why?
|
Cyclin D1 | 1 | 2004 | 83 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 74 | 0.060 |
Why?
|
Piperidines | 2 | 1995 | 181 | 0.060 |
Why?
|
Caspase Inhibitors | 1 | 2003 | 33 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2004 | 203 | 0.060 |
Why?
|
Amides | 1 | 2003 | 60 | 0.060 |
Why?
|
HLA Antigens | 1 | 2004 | 232 | 0.060 |
Why?
|
Treatment Failure | 2 | 2014 | 286 | 0.060 |
Why?
|
Phospholipases A2 | 2 | 1993 | 44 | 0.060 |
Why?
|
Acetophenones | 2 | 1993 | 27 | 0.060 |
Why?
|
Cell Membrane | 2 | 2003 | 666 | 0.060 |
Why?
|
Ovalbumin | 1 | 2003 | 109 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 1 | 2002 | 121 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2016 | 1019 | 0.050 |
Why?
|
rho-Associated Kinases | 1 | 2003 | 159 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2003 | 646 | 0.050 |
Why?
|
Receptors, Glucocorticoid | 1 | 2003 | 120 | 0.050 |
Why?
|
Trefoil Factor-2 | 1 | 2001 | 1 | 0.050 |
Why?
|
Trefoil Factor-3 | 1 | 2001 | 2 | 0.050 |
Why?
|
Bronchitis, Chronic | 1 | 2001 | 2 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 2271 | 0.050 |
Why?
|
Steroids | 1 | 2002 | 177 | 0.050 |
Why?
|
Chromosome Mapping | 1 | 2004 | 1074 | 0.050 |
Why?
|
Receptors, Fibronectin | 1 | 2001 | 5 | 0.050 |
Why?
|
Pyridines | 1 | 2003 | 310 | 0.050 |
Why?
|
Vinculin | 1 | 2001 | 9 | 0.050 |
Why?
|
Receptors, Laminin | 1 | 2001 | 6 | 0.050 |
Why?
|
Caspase 8 | 1 | 2001 | 34 | 0.050 |
Why?
|
Caspase 9 | 1 | 2001 | 48 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 379 | 0.050 |
Why?
|
Dystroglycans | 1 | 2001 | 15 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2003 | 1015 | 0.050 |
Why?
|
Peptides, Cyclic | 1 | 2001 | 43 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2001 | 145 | 0.050 |
Why?
|
Paxillin | 1 | 2001 | 59 | 0.050 |
Why?
|
Retrospective Studies | 1 | 2014 | 8496 | 0.050 |
Why?
|
Caspases | 1 | 2001 | 155 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 1047 | 0.050 |
Why?
|
Focal Adhesions | 1 | 2001 | 69 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 1 | 2001 | 316 | 0.050 |
Why?
|
Animals, Newborn | 3 | 1997 | 510 | 0.050 |
Why?
|
DNA Primers | 1 | 2001 | 543 | 0.050 |
Why?
|
Signal Transduction | 2 | 2015 | 3243 | 0.040 |
Why?
|
Nose Neoplasms | 1 | 1999 | 31 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2014 | 1824 | 0.040 |
Why?
|
Phosphoproteins | 1 | 2001 | 255 | 0.040 |
Why?
|
Simian virus 40 | 1 | 1999 | 35 | 0.040 |
Why?
|
Leucine | 1 | 1999 | 67 | 0.040 |
Why?
|
Glycoconjugates | 1 | 1999 | 10 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1999 | 130 | 0.040 |
Why?
|
Nasal Polyps | 1 | 1999 | 58 | 0.040 |
Why?
|
Bronchial Hyperreactivity | 2 | 2004 | 77 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2000 | 234 | 0.040 |
Why?
|
Fas Ligand Protein | 1 | 1998 | 49 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 928 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 1999 | 123 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 1997 | 1221 | 0.040 |
Why?
|
ErbB Receptors | 1 | 2001 | 485 | 0.040 |
Why?
|
Atropine | 2 | 1996 | 59 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2001 | 231 | 0.040 |
Why?
|
Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 1 | 1997 | 3 | 0.040 |
Why?
|
Prostaglandin Antagonists | 1 | 1997 | 7 | 0.040 |
Why?
|
Receptors, Prostaglandin E | 1 | 1997 | 5 | 0.040 |
Why?
|
Xanthones | 1 | 1997 | 11 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2001 | 449 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2001 | 853 | 0.040 |
Why?
|
Receptors, Bombesin | 1 | 1997 | 1 | 0.040 |
Why?
|
Gastrin-Releasing Peptide | 1 | 1997 | 3 | 0.040 |
Why?
|
Leukotriene C4 | 2 | 1994 | 21 | 0.040 |
Why?
|
Glycopeptides | 1 | 1997 | 16 | 0.040 |
Why?
|
Neprilysin | 1 | 1997 | 42 | 0.040 |
Why?
|
Visual Analog Scale | 1 | 2016 | 14 | 0.040 |
Why?
|
Platelet Activating Factor | 3 | 1997 | 53 | 0.040 |
Why?
|
Videotape Recording | 1 | 2017 | 47 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 1997 | 72 | 0.040 |
Why?
|
Self Administration | 1 | 2017 | 73 | 0.040 |
Why?
|
Regeneration | 1 | 1997 | 143 | 0.040 |
Why?
|
Child | 3 | 2014 | 6928 | 0.040 |
Why?
|
Indomethacin | 2 | 1997 | 59 | 0.030 |
Why?
|
Cations | 1 | 1996 | 30 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 1996 | 40 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 1996 | 66 | 0.030 |
Why?
|
Proteins | 1 | 2001 | 777 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 67 | 0.030 |
Why?
|
Peroxidase | 2 | 1993 | 51 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 1995 | 57 | 0.030 |
Why?
|
Data Mining | 1 | 2015 | 42 | 0.030 |
Why?
|
S Phase | 1 | 1995 | 62 | 0.030 |
Why?
|
Neurokinin-1 Receptor Antagonists | 1 | 1995 | 34 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2014 | 15 | 0.030 |
Why?
|
Genes | 1 | 2015 | 305 | 0.030 |
Why?
|
Intermediate Filament Proteins | 1 | 2014 | 35 | 0.030 |
Why?
|
Kidney | 1 | 2001 | 1242 | 0.030 |
Why?
|
Costa Rica | 1 | 2014 | 15 | 0.030 |
Why?
|
Epidermis | 1 | 2014 | 100 | 0.030 |
Why?
|
Cell Communication | 1 | 1995 | 194 | 0.030 |
Why?
|
Regression Analysis | 1 | 2015 | 596 | 0.030 |
Why?
|
Dermatitis, Atopic | 1 | 2014 | 52 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 1994 | 36 | 0.030 |
Why?
|
Thymidine | 1 | 1993 | 59 | 0.030 |
Why?
|
Keratinocytes | 1 | 2014 | 143 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 1998 | 1135 | 0.030 |
Why?
|
Blood Cells | 1 | 1993 | 33 | 0.030 |
Why?
|
Inpatients | 1 | 2017 | 298 | 0.030 |
Why?
|
Quinacrine | 1 | 1993 | 14 | 0.030 |
Why?
|
Macrophage-1 Antigen | 1 | 1993 | 17 | 0.030 |
Why?
|
SRS-A | 1 | 1993 | 27 | 0.030 |
Why?
|
Centrifugation, Density Gradient | 1 | 1993 | 112 | 0.030 |
Why?
|
Gene Deletion | 1 | 2014 | 329 | 0.030 |
Why?
|
ROC Curve | 1 | 1996 | 752 | 0.030 |
Why?
|
Propranolol | 2 | 1994 | 45 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 689 | 0.030 |
Why?
|
Down-Regulation | 1 | 2015 | 506 | 0.030 |
Why?
|
Arachidonic Acid | 1 | 1993 | 63 | 0.030 |
Why?
|
Fetal Blood | 1 | 1993 | 90 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 322 | 0.030 |
Why?
|
Superoxides | 1 | 1993 | 73 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 296 | 0.030 |
Why?
|
Interferons | 1 | 2013 | 133 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2015 | 1001 | 0.030 |
Why?
|
Cell Separation | 1 | 1993 | 196 | 0.030 |
Why?
|
Interleukins | 1 | 2013 | 134 | 0.030 |
Why?
|
Maternal Exposure | 1 | 2013 | 57 | 0.030 |
Why?
|
Interferon-beta | 1 | 2013 | 125 | 0.030 |
Why?
|
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1992 | 4 | 0.030 |
Why?
|
Eicosanoids | 1 | 1992 | 16 | 0.030 |
Why?
|
RNA, Messenger | 1 | 1998 | 1981 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 1993 | 163 | 0.030 |
Why?
|
Administration, Oral | 1 | 2014 | 684 | 0.030 |
Why?
|
Receptors, Muscarinic | 1 | 1992 | 49 | 0.030 |
Why?
|
Chloralose | 1 | 1992 | 6 | 0.030 |
Why?
|
Dinoprost | 1 | 1992 | 26 | 0.030 |
Why?
|
HeLa Cells | 1 | 2013 | 498 | 0.030 |
Why?
|
Iliac Artery | 1 | 1992 | 35 | 0.030 |
Why?
|
Medicare | 1 | 1996 | 410 | 0.030 |
Why?
|
Epoprostenol | 1 | 1992 | 46 | 0.030 |
Why?
|
Amitrole | 1 | 1991 | 3 | 0.030 |
Why?
|
Saphenous Vein | 1 | 1992 | 61 | 0.030 |
Why?
|
Comorbidity | 1 | 1996 | 944 | 0.030 |
Why?
|
Administration, Topical | 1 | 1992 | 95 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 1075 | 0.030 |
Why?
|
Neutrophils | 1 | 1993 | 307 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2014 | 482 | 0.030 |
Why?
|
Cell Survival | 1 | 1993 | 969 | 0.020 |
Why?
|
Homeostasis | 1 | 1993 | 409 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 1991 | 62 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 819 | 0.020 |
Why?
|
Hemodynamics | 2 | 1992 | 711 | 0.020 |
Why?
|
T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2009 | 7 | 0.020 |
Why?
|
Chromones | 1 | 2009 | 28 | 0.020 |
Why?
|
Genomics | 1 | 2015 | 720 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 1992 | 228 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2009 | 48 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2014 | 1924 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2009 | 6 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2009 | 134 | 0.020 |
Why?
|
Age Factors | 1 | 2014 | 1852 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2007 | 1753 | 0.020 |
Why?
|
Morpholines | 1 | 2009 | 65 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 1990 | 188 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2009 | 73 | 0.020 |
Why?
|
p-Methoxy-N-methylphenethylamine | 1 | 1989 | 5 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 2360 | 0.020 |
Why?
|
Nitroprusside | 1 | 1989 | 32 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 268 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1990 | 493 | 0.020 |
Why?
|
Ascaris | 1 | 1989 | 5 | 0.020 |
Why?
|
Dimethylphenylpiperazinium Iodide | 1 | 1989 | 8 | 0.020 |
Why?
|
Parasympatholytics | 1 | 1989 | 18 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 1991 | 320 | 0.020 |
Why?
|
Cohort Studies | 1 | 1996 | 2768 | 0.020 |
Why?
|
Catecholamines | 1 | 1989 | 88 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 1991 | 334 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2001 | 2262 | 0.020 |
Why?
|
Genotype | 1 | 2013 | 1852 | 0.020 |
Why?
|
Blood Platelets | 1 | 1988 | 149 | 0.020 |
Why?
|
Prognosis | 1 | 2015 | 3680 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2014 | 2231 | 0.020 |
Why?
|
Drug Interactions | 1 | 1988 | 248 | 0.020 |
Why?
|
Cicer | 1 | 2007 | 1 | 0.020 |
Why?
|
Tunicamycin | 1 | 2007 | 12 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 1996 | 6513 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 3613 | 0.020 |
Why?
|
Hypersensitivity | 1 | 1989 | 154 | 0.020 |
Why?
|
Oxygen | 1 | 1992 | 726 | 0.020 |
Why?
|
Muscle Tonus | 2 | 1997 | 19 | 0.020 |
Why?
|
Ligands | 1 | 2007 | 433 | 0.020 |
Why?
|
Protein Binding | 1 | 2009 | 1457 | 0.020 |
Why?
|
Electric Stimulation | 2 | 1997 | 347 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 7998 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 2426 | 0.010 |
Why?
|
Lipoxygenase Inhibitors | 2 | 1993 | 33 | 0.010 |
Why?
|
United States | 1 | 1996 | 6681 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 1749 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 747 | 0.010 |
Why?
|
Genetic Testing | 1 | 2004 | 535 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2007 | 1196 | 0.010 |
Why?
|
Respiratory Hypersensitivity | 1 | 1999 | 41 | 0.010 |
Why?
|
Drug Synergism | 1 | 2000 | 303 | 0.010 |
Why?
|
Nasal Mucosa | 1 | 1999 | 186 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 674 | 0.010 |
Why?
|
Tissue Extracts | 1 | 1997 | 24 | 0.010 |
Why?
|
Receptors, Prostaglandin E, EP1 Subtype | 1 | 1997 | 3 | 0.010 |
Why?
|
Myelin Basic Protein | 1 | 1997 | 49 | 0.010 |
Why?
|
Iloprost | 1 | 1997 | 15 | 0.010 |
Why?
|
Xanthenes | 1 | 1997 | 23 | 0.010 |
Why?
|
Biphenyl Compounds | 1 | 1997 | 68 | 0.010 |
Why?
|
Coculture Techniques | 1 | 1997 | 164 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 376 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2000 | 683 | 0.010 |
Why?
|
Hypertonic Solutions | 1 | 1995 | 17 | 0.010 |
Why?
|
Saline Solution, Hypertonic | 1 | 1995 | 24 | 0.010 |
Why?
|
Mannitol | 1 | 1995 | 49 | 0.010 |
Why?
|
Glycerol | 1 | 1995 | 33 | 0.010 |
Why?
|
Sucrose | 1 | 1995 | 64 | 0.010 |
Why?
|
Cold Temperature | 1 | 1995 | 157 | 0.010 |
Why?
|
Cytoplasmic Granules | 1 | 1994 | 94 | 0.010 |
Why?
|
Albuterol | 1 | 1994 | 35 | 0.010 |
Why?
|
Methacholine Chloride | 1 | 1993 | 64 | 0.010 |
Why?
|
L-Selectin | 1 | 1993 | 16 | 0.010 |
Why?
|
Phenyl Ethers | 1 | 1993 | 13 | 0.010 |
Why?
|
Interleukin-5 | 1 | 1993 | 36 | 0.010 |
Why?
|
Acetamides | 1 | 1993 | 26 | 0.010 |
Why?
|
Adolescent | 2 | 1999 | 8984 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 137 | 0.010 |
Why?
|
Erythropoietin | 1 | 1993 | 91 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 1992 | 49 | 0.010 |
Why?
|
Polytetrafluoroethylene | 1 | 1992 | 74 | 0.010 |
Why?
|
Sheep | 1 | 1992 | 239 | 0.010 |
Why?
|
Hyperplasia | 1 | 1992 | 148 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1991 | 45 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1991 | 274 | 0.010 |
Why?
|
Pneumothorax | 1 | 1991 | 52 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 1992 | 267 | 0.010 |
Why?
|
Calcium | 1 | 1995 | 1156 | 0.010 |
Why?
|
Anesthesia | 1 | 1992 | 164 | 0.010 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1989 | 15 | 0.010 |
Why?
|
Bucladesine | 1 | 1989 | 13 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 1991 | 144 | 0.010 |
Why?
|
Colforsin | 1 | 1989 | 74 | 0.010 |
Why?
|
Biological Factors | 1 | 1989 | 18 | 0.010 |
Why?
|
Phospholipid Ethers | 1 | 1988 | 4 | 0.010 |
Why?
|
Methysergide | 1 | 1988 | 6 | 0.010 |
Why?
|
Tachyphylaxis | 1 | 1988 | 14 | 0.010 |
Why?
|
Intensive Care Units | 1 | 1991 | 374 | 0.000 |
Why?
|